Alan H. Auerbach

2018

In 2018, Alan H. Auerbach earned a total compensation of $6.2M as President and Chief Executive Officer at Puma Biotechnology, a 121% increase compared to previous year.

Compensation breakdown

Bonus$541,441
Option Awards$2,672,286
Salary$757,260
Stock Awards$2,169,303
Other$12,260
Total$6,152,550

Auerbach received $2.7M in option awards, accounting for 43% of the total pay in 2018.

Auerbach also received $541.4K in bonus, $757.3K in salary, $2.2M in stock awards and $12.3K in other compensation.

Rankings

In 2018, Alan H. Auerbach's compensation ranked 1,514th out of 14,244 executives tracked by ExecPay. In other words, Auerbach earned more than 89.4% of executives.

ClassificationRankingPercentile
All
1,514
out of 14,244
89th
Division
Manufacturing
532
out of 5,758
91st
Major group
Chemicals And Allied Products
166
out of 2,119
92nd
Industry group
Drugs
131
out of 1,808
93rd
Industry
Pharmaceutical Preparations
97
out of 1,382
93rd
Source: SEC filing on April 29, 2019.

Auerbach's colleagues

We found five more compensation records of executives who worked with Alan H. Auerbach at Puma Biotechnology in 2018.

2018

Douglas Hons

Puma Biotechnology

Senior Vice President, Regulatory Affairs, Medical Writing and Project Management

2018

Maximo Nougues

Puma Biotechnology

Chief Financial Officer

2018

Steven Lo

Puma Biotechnology

Chief Commercial Officer

2018

Richard Bryce

Puma Biotechnology

B, MRCGP and MFPM Senior Vice President, Clinical Research and Development

2018

Charles Eyler

Puma Biotechnology

Senior Vice President, Finance and Administration

News

You may also like